By Shania Kennedy
June 12, 2023 – A study published last week in Urology Practice demonstrated that ChatGPT performed poorly on the 2022 American Urological Association (AUA) Self-assessment Study Program exam, indicating that the tool may…
Continue Reading
By Mark Melchionna
June 09, 2023 – Launched by Cedars-Sinai, a telehealth-based service known as the Virtual Second Opinion Program aims to assist patients needing cardiac, spine, or gynecologic care through second-opinion consultations with specialists and…
Continue Reading
Italy-based healthcare agency, consultancy and digital health group, Healthware, and the Digital Therapeutics Alliance, a nonprofit organization based in Virginia that provides thought leadership and education to advance digital therapeutic adoption, today announced the…
Continue Reading
Italy-based healthcare agency, consultancy and digital health group, Healthware, and the Digital Therapeutics Alliance, a nonprofit organization based in Virginia that provides thought leadership and education to advance digital therapeutic adoption, today announced the…
Continue Reading
By Mark Melchionna
June 08, 2023 – After receiving approval from its Board of Regents, Texas A&M University plans to add a Telehealth Institute to its health system, supporting virtual care-related research, education, and clinical services.
Advancing…
Continue Reading
By Mark Melchionna
June 05, 2023 – A report from the University of Washington Center for Health and Workforce Studies showed that although there was limited information about how medical assistants (MAs) use telehealth, researchers found…
Continue Reading
The Bayer Consumer Health Division has launched a business unit that will focus on developing new precision health products, enabling people to use digital solutions to take greater control of their health.Tasked with identifying…
Continue Reading
ChatGPT-3 and ChatGPT-4, two iterations of the natural language processing tool, failed the American College of Gastroenterology self-assessment tests, scoring 65.1% and 62.4% respectively. The study concluded that ChatGPT should not be used for…
Continue Reading
The Michael J. Fox Foundation (MJFF) has announced a partnership with New York-based H1, a healthcare data company, to streamline its search for physicians actively treating Parkinson’s disease patients and gather information on patient…
Continue Reading
What You Should Know:
H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the world’s largest nonprofit funder of Parkinson’s research, The Michael J. Fox Foundation (MJFF), has selected its Trial Landscape solution to…
Continue Reading
